Список литературы

1. Незнанов Н.Г., Абриталин Е.Ю., Александровский Ю.А. Психиатрия. Национальное руководство/ed. Незнанов Н.Г., Александровский Ю.А. ГЭОТАР-Медиа, 2022. 1 - 1008 p.

2. Психические расстройства и расстройства поведения (F00 - F99). (Класс V МКБ-10, адаптированный для использования в Российской Федерации)./ed. Казаковцева Б.А., Голланд В.Б. Москва: Минздрав России, 1998. 512 p.

3. Корсаков С.С. Курс психиатрии. 2nd ed. типо-литография В.Рихтер, 1901. Vol. 2. 1 - 480 p.

4. Chandrakumar A., Bhardwaj A., Jong G.W. 't. Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis//Journal of Basic and Clinical Physiology and Pharmacology. De Gruyter, 2019. Vol. 30, N 2. P. 153 - 162.

5. Habas E. et al. Wernicke Encephalopathy: An Updated Narrative Review//Saudi J Med Med Sci. 2023. Vol. 11, N 3. P. 193 - 200.

6. Diagnostic and statistical manual of mental disorders: DSM-5-TR. Fifth edition, text revision/ed. American Psychiatric Association. Washington, DC: American Psychiatric Association Publishing, 2022. 1050 p.

7. Наркология: Национальное руководство/ed. Иванец Н.Н., Анохина И.П., Винникова М.А. Москва: ГЭОТАР-Медиа, 2016. 944 p.

8. Ahlbach C. et al. Amnestic Syndrome and Bilateral Hippocampal Diffusion Abnormalities From Opioid Use//Neurol Clin Pract. 2021. Vol. 11, N 5. P. e801 - e802.

9. Duru U.B. et al. An Unusual Amnestic Syndrome Associated With Combined Fentanyl and Cocaine Use//Ann Intern Med. 2018. Vol. 168, N 10. P. 747 - 748.

10. Br ggemann N. et al. Acute amnestic syndrome due to MDMA exposure//J Neurol. 2016. Vol. 263, N 5. P. 1022 - 1023.

11. Huang D., Lukas R.V. Complete Bilateral Hippocampal Diffusion Restriction and Reversible Amnesia Following Opiate, Cocaine, and Benzodiazepine Abuse//Cureus. 2021.

12. Westermeyer J.J. et al. Identifying, Assessing, and Treating Korsakoff Syndrome Patients: Updated Perspectives//The Journal of Nervous and Mental Disease. 2021. Vol. 209, N 8. P. 592.

13. Arts N.J., Walvoort S.J., Kessels R.P. Korsakoff's syndrome: a critical review//Neuropsychiatr Dis Treat. 2017. Vol. 13. P. 2875 - 2890.

14. Popa I. et al. Korsakoff syndrome: An overlook (Review)//Exp Ther Med. 2021. Vol. 22, N 4. P. 1132.

15. Galvin R. et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy//European Journal of Neurology. 2010. Vol. 17, N 12. P. 1408 - 1418.

16. Palm A. et al. Incidence and mortality of alcohol related dementia and Wernicke Korsakoff syndrome: A nationwide register study//Int J Geriatr Psychiatry. 2022. Vol. 37, N 8. P. 10.1002/gps.5775.

17. Rasiah R. et al. Hospital Outcomes in Medical Patients With Alcohol-Related and Non-Alcohol-Related Wernicke Encephalopathy//Mayo Clinic Proceedings. Elsevier, 2024. Vol. 99, N 5. P. 740 - 753.

18. Масякин А.В. et al. Психические и поведенческие расстройства, связанные с употреблением психоактивных веществ, в Москве в 2021 - 2022 годах. Статистический сборник. Москва: ГБУЗ "МНПЦ наркологии ДЗМ", 2024. P. 37.

19. Наркология: национальное руководство. 3-е изд./ред. Иванец Н.Н., Винникова М.А. Москва: ГЭОТАР-Медиа, 2024. 848 p.

20. Gerridzen I.J. et al. Neuropsychiatric Symptoms in People With Korsakoff Syndrome and Other Alcohol-Related Cognitive Disorders Living in Specialized Long-Term Care Facilities: Prevalence, Severity, and Associated Caregiver Distress//Journal of the American Medical Directors Association. Elsevier, 2018. Vol. 19, N 3. P. 240 - 247.

21. Fidder H. et al. Impaired Awareness in People with Severe Alcohol-Related Cognitive Deficits Including Korskoff's Syndrome: A Network Analysis//J Clin Med. 2023. Vol. 12, N 9. P. 3139.

22. Caine D. et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy.//Journal of Neurology, Neurosurgery & Psychiatry. BMJ Publishing Group Ltd, 1997. Vol. 62, N 1. P. 51 - 60.

23. Novo-Veleiro I. et al. Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study//Drug and Alcohol Dependence. 2022. Vol. 230. P. 109186.

24. van Dam M.J. et al. Health problems and care needs in patients with Korsakoff's syndrome: A systematic review//Journal of Psychiatric and Mental Health Nursing. 2020. Vol. 27, N 4. P. 460 - 481.

25. Lin S. et al. Prevalence and Improvement of Caine-Positive Wernicke-Korsakoff Syndrome in Psychiatric Inpatient Admissions//Psychosomatics. 2020. Vol. 61, N 1. P. 31 - 38.

26. Наркология: Национальное руководство. Краткое издание/под ред. Н.Н. Иванца, М.А. Винниковой. - Москва: Общество с ограниченной ответственностью Издательская группа "ГЭОТАР-Медиа", 2020. - 704 с.

27. Наркология: национальная руководство, под ред. Н.Н. Иванца, И.П. Анохиной, М.А. Винниковой - 2-е издание перераб и доп. М: ГЭОТАР-Медиа, 2016. - 944 с.

28. Интенсивная терапия: Национальное руководство. Краткое издание в 2 томах/под ред. И.Б. Заболотских, Д.Н. Проценко - 3-е издание. - Москва: Общество с ограниченной ответственностью Издательская группа "ГЭОТАР-Медиа", 2024. - 544 с.

29. Алкоголизм. Руководство для врачей. Под редакцией Н.Н. Иванца, М.А. Винниковой - М., ООО "Издательство "Медицинское информационное агентство", 2011. - 856 с.

30. Клинические и организационные вопросы наркологии/Под редакцией Кошкиной Е.А. М.: Гениус-Медиа, 2011. - 580 с.

31. Tavakoli H.R., Hull M., Michael Okasinski LT. Review of Current Clinical Biomarkers for the Detection of Alcohol Dependence//Innov Clin Neurosci. 2011. Vol. 8, N 3. P. 26 - 33.

32. Kalas M.A. et al. Abnormal liver enzymes: A review for clinicians//World J Hepatol. 2021. Vol. 13, N 11. P. 1688 - 1698.

33. Andresen-Streichert* H. et al. Alcohol Biomarkers in Clinical and Forensic Contexts//Dtsch Arztebl Int. 2018. Vol. 115, N 18. P. 309 - 315.

34. Cohen S.M., Alexander R.S., Holt S.R. The Spectrum of Alcohol Use: Epidemiology, Diagnosis, and Treatment//Med Clin North Am. 2022. Vol. 106, N 1. P. 43 - 60.

35. Barash J.A. et al. Opioid-associated amnestic syndrome: Description of the syndrome and validation of a proposed definition//Journal of the Neurological Sciences. 2020. Vol. 417. P. 117048.

36. Tsai C. et al. Bilateral Acute Hippocampal Ischemia in Two Patients Abusing Cocaine: What is the Outcome?//Cureus. 2022.

37. Todaro D.R. et al. Hippocampal volume loss in individuals with a history of non-fatal opioid overdose//Addict Biol. 2023. Vol. 28, N 10. P. e13336.

38. Zahr N.M. Alcohol Use Disorder and Dementia: A Review//Alcohol Res. 2024. Vol. 44, N 1. P. 03.

39. Spindler C. et al. A coordinate-based meta-analysis of white matter alterations in patients with alcohol use disorder//Translational Psychiatry. Nature Publishing Group, 2022. Vol. 12.

40. Jung Y.-C., Chanraud S., Sullivan E.V. Neuroimaging of Wernicke's Encephalopathy and Korsakoff's Syndrome//Neuropsychology review. NIH Public Access, 2012. Vol. 22, N 2. P. 170.

41. Nikiforov I.I. et al. Neurological complications of alcoholism//RJTAO. 2017. Vol. 9, N 4. P. 95 - 100.

42. Ko K.Y. et al. Screening Tools for Cognitive Impairment in Adults with Substance Use Disorders: A Systematic Review//J Int Neuropsychol Soc. 2022. Vol. 28, N 7. P. 756 - 779.

43. Vetrova M.V. et al. Assessment of cognitive functions in individuals with substance use disorder and HIV//. immunosupr. 2022. Vol. 13, N 4. P. 21 - 32.

44. Jones L. et al. Informing the development of diagnostic criteria for differential diagnosis of alcohol-related cognitive impairment (ARCI) among heavy drinkers: A systematic scoping review//PLoS One. 2023. Vol. 18, N 2. P. e0280749.

45. Nasreddine Z.S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment//J Am Geriatr Soc. 2005. Vol. 53, N 4. P. 695 - 699.

46. Freud T. et al. Validation of the Russian Version of the MoCA Test as a Cognitive Screening Instrument in Cognitively Asymptomatic Older Individuals and Those With Mild Cognitive Impairment//Front Med (Lausanne). 2020. Vol. 7. P. 447.

47. Wester A. J. et al. The Montreal Cognitive Assessment (MoCA) as a measure of severity of amnesia in patients with alcohol-related cognitive impairments and Korsakoff syndrome.//Clin. Neuropsychiatry. 2013. Vol. 3 - 4, N 10. P. 134 - 141.

48. Oudman E. et al. The Montreal Cognitive Assessment (MoCA) is Superior to the Mini Mental State Examination (MMSE) in Detection of Korsakoff's Syndrome//The Clinical Neuropsychologist. 2014. Vol. 28, N 7. P. 1123 - 1132.

49. Heirene R., John B., Roderique-Davies G. Identification and Evaluation of Neuropsychological Tools Used in the Assessment of Alcohol-Related Cognitive Impairment: A Systematic Review//Front. Psychol. Frontiers, 2018. Vol. 9.

50. Mistarz N. et al. Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review//Neuroscience & Biobehavioral Reviews. 2021. Vol. 125. P. 608 - 626.

51. Caballeria E. et al. A systematic review of treatments for alcohol-related cognitive impairment: lessons from the past and gaps for future interventions//Psychological Medicine. 2020. Vol. 50, N 13. P. 2113 - 2127.

52. A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome//Med Arh. 2003. Vol. 57, N 3. P. 149 - 150.

53. Cheon Y. et al. The effect of 12-week open-label memantine treatment on cognitive functionimprovement in patients with alcohol-related dementia//Int J Neuropsychopharmacol. 2008. Vol. 11, N 7. P. 971 - 983.

54. Parsons C. et al. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia//Cochrane Database Syst Rev. 2021. Vol. 2, N 2. P. CD009081.

55. Dingwall K.M. et al. What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial//Alcohol Clin Exp Res. 2022. Vol. 46, N 6. P. 1133 - 1147.

56. Day E. et al. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol//Cochrane Database of Systematic Reviews/ed. Cochrane Dementia and Cognitive Improvement Group. 2013.

57. Pruckner N. et al. Thiamine Substitution in Alcohol Use Disorder: A Narrative Review of Medical Guidelines//Eur Addict Res. 2019. Vol. 25, N 3. P. 103 - 110.

58. Kolykhalov I.V., Androsova L.V., Gavrilova S.I. [Clinical and immunological effects of choline alfoscerate in the treatment of amnestic type Mild Cognitive Impairment]//Zh Nevrol Psikhiatr Im S S Korsakova. 2022. Vol. 122, N 11. Vyp. 2. P. 59 - 66.

59. Jeon J, Lee SY, Lee S, et al. Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial.//BMC Geriatr. 2024. Vol. 24 N 1 P. 774.

60. Palm A. et al. Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke-Korsakoff Syndrome: A Nationwide Register Study in Finland//Journal of Clinical Medicine. Multidisciplinary Digital Publishing Institute (MDPI), 2023. Vol. 12, N 13.

61. Eva L. et al. Neuropsychiatric and Neuropsychological Aspects of Alcohol-Related Cognitive Disorders: An In-Depth Review of Wernicke's Encephalopathy and Korsakoff's Syndrome//J Clin Med. 2023. Vol. 12, N 18. P. 6101.

62. Tampi R.R. et al. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses//Ther Adv Chronic Dis. 2016. Vol. 7, N 5. P. 229 - 245.

63. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia//Cochrane Database of Systematic Reviews/ed. Cochrane Dementia and Cognitive Improvement Group. 2021. Vol. 2022, N 1.

64. Van Leeuwen E. et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia//Cochrane Database of Systematic Reviews/ed. Cochrane Dementia and Cognitive Improvement Group. 2018. Vol. 2022, N 4.

65. Archer M. et al. Community reinforcement and family training and rates of treatment entry: a systematic review//Addiction. 2020. Vol. 115, N 6. P. 1024 - 1037.

66. Науменко А.А., Громова Д.О., Преображенская И.С. Когнитивный тренинг и реабилитация пациентов с когнитивными нарушениями//Доктор.Ру. 2017. N 11 (140). P. 31 - 38.

67. Caetano T. et al. Cognitive Training Effectiveness on Memory, Executive Functioning, and Processing Speed in Individuals With Substance Use Disorders: A Systematic Review//Front Psychol. 2021. Vol. 12. P. 730165.

68. Bell M.D., Vissicchio N.A., Weinstein A.J. Cognitive Training and Work Therapy for the Treatment of Verbal Learning and Memory Deficits in Veterans With Alcohol Use Disorders//J Dual Diagn. 2016. Vol. 12, N 1. P. 83 - 89.

69. Oudman E. et al. Acquisition of an instrumental activity of daily living in patients with Korsakoff's syndrome: A comparison of trial and error and errorless learning//Neuropsychological Rehabilitation. 2013. Vol. 23, N 6. P. 888 - 913.

70. Kessels R.P.C., Van Loon E., Wester A.J. Route learning in amnesia: a comparison of trial-and-error and errorless learning in patients with the Korsakoff syndrome//Clin Rehabil. 2007. Vol. 21, N 10. P. 905 - 911.

71. Rensen Y.C. et al. The effect of errorless learning on quality of life in patients with Korsakoff's syndrome//Neuropsychiatr Dis Treat. 2017. Vol. 13. P. 2867 - 2873.

72. Rensen Y.C.M. et al. The effect of errorless learning on psychotic and affective symptoms, as well as aggression and apathy in patients with Korsakoff's syndrome in long-term care facilities//Int Psychogeriatr. 2019. Vol. 31, N 1. P. 39 - 47.

73. Komatsu S.-I. et al. Errorless and Effortful Processes Involved in the Learning of Face-name Associations by Patients with Alcoholic Korsakoff's Syndrome//Neuropsychological Rehabilitation. Routledge, 2000. Vol. 10, N 2. P. 113 - 132.

74. Godfrey H.P., Knight R.G. Cognitive rehabilitation of memory functioning in amnesiac alcoholics.//Journal of Consulting and Clinical Psychology. 1985. Vol. 53, N 4. P. 555 - 557.

75. Преображенская И.С. et al. Когнитивный тренинг для пациентов с умеренными когнитивными расстройствами. Ижевск: ООО "Принт," 2022. 300 p.

76. Пекарска И. et al. Когнитивный тренинг: упражнение интеллекта и речи в пожилом возрасте. Москва: Издательство Перо, 2021. 68 p.